择期开窗腔内主动脉瘤修复术的中心水平结局:基于血管质量倡议数据库的分析
基于美国血管质量倡议胸主动脉腔内修复/复杂EVAR数据库2014-2021年数据,分析163个中心4302例择期开窗/分支腔内主动脉修复术。院内死亡率不随中心手术量变化(Q1 3.3% vs Q4 4.2%,P=0.308),但高容量组主要并发症更高(Q4 20.1%,校正P<0.001),1年生存无显著差异。
要点
- 院内死亡率不随中心手术量变化(Q1 3.3% vs Q4 4.2%,P=0.308)。
- 高容量组主要并发症率更高(Q4 20.1%,校正P<0.001)。
- 1年生存率在各中心容量组间无显著差异。
核心结论
- 在开展复杂腔内主动脉修复术的中心中,院内死亡率与手术量无关,但并发症率和内漏可能与手术量相关。
- 作者认为应进一步研究按年手术量分层的长期结局,特别是移植物耐久性和瘤囊扩张。
研究设计与样本
- 回顾性分析美国血管质量倡议胸主动脉腔内修复/复杂EVAR数据库2014-2021年数据。
- 纳入163个中心共4302例择期开窗/分支腔内胸腹主动脉及复杂腹主动脉瘤修复术。
- 按年平均手术量四分位数将中心分组,采用多变量回归分析院内死亡率,Kaplan-Meier估计、对数秩检验和混合效应Cox回归评估1年生存。
主要发现
- 院内死亡率不随医院手术量变化:Q1为35/1059(3.3%),Q2为30/1063(2.8%),Q3为33/1120(2.9%),Q4为44/1060(4.2%),P=0.308。
- 高容量组主要并发症率更高:Q1为14.9%,Q2为12.8%,Q3为13.3%,Q4为20.1%,校正P<0.001。
- 医生修改移植物在高容量中心更常用:Q1为4.5%,Q2为18.7%,Q3为11.3%,Q4为19.2%,P<0.001。
- 术后即刻任何内漏发生率在高容量中心更低:Q1为34.9%,Q2为32.8%,Q3为30.0%,Q4为29.0%,P=0.003。
- 多变量分析中,与Q4相比,院内死亡率与中心容量无关:Q1的OR为1.1(95%CI 0.6-1.9),Q2为0.6(95%CI 0.4-1.1),Q3为0.9(95%CI 0.5-1.5),所有P>0.05。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Hospital volume is associated with mortality after open aortic aneurysm repair. Fenestrated and branched endovascular aortic repair (B-FEVAR) has been increasingly used for repair of complex thoracoabdominal and juxtarenal aneurysms, but evidence of a center-volume relationship is limited. We aimed to measure the association of center volume with in-hospital mortality, postoperative outcomes, and 1-year survival following B-FEVAR. METHODS: Patients undergoing elective endovascular thoracoabdominal and complex abdominal aneurysm repair with branch intervention (2014-2021) listed within the national Vascular Quality Initiative Thoracic Endovascular Aortic Repair/Complex EVAR database were analyzed. Centers were grouped into quartiles by mean annual procedure volume. Multivariable regression was used to evaluate the effect of center volume on in-hospital mortality adjusting for baseline and procedural characteristics. Kaplan-Meier estimation, log rank test, and mixed effects Cox regression were used to evaluate 1-year survival. RESULTS: A total of 4302 adult elective F-BEVAR procedures were identified at a total of 163 centers. In-hospital mortality did not differ by hospital volume (quartile [Q]1 = 35/1059 [3.3%]; Q2 = 30/1063 [2.8%]; Q3 = 33/1120 [2.9%]; and Q4 = 44/1060 [4.2%]; P = .308). The high volume group had a higher rate of major complication (Q1 = 14.9%; Q2 = 12.8%; Q3 = 13.3%; and Q4 = 20.1%; adjusted P < .001). Physician-modified grafts were more frequently employed in high-volume centers (Q1 = 4.5%; Q2 = 18.7%; Q3 = 11.3%; and Q4 = 19.2%; P < .001), with a decreased incidence of any endoleak noted at the end of the procedure (Q1 = 34.9%; Q2 = 32.8%; Q3 = 30.0%; and Q4 = 29.0%; P = .003). In the multivariable analysis, in-hospital mortality was not associated with center volume, comparing very low volume to medium- and high-volume centers (odds ratio [95% confidence interval] vs Q4: Q1 = 1.1 [0.6-1.9], Q2 = 0.6 [0.4-1.1], and Q3 = 0.9 [0.5-1.5]; all P > .05). No significant difference was found in 1-year survival between center volume groups. CONCLUSIONS: In-hospital mortality is not associated with procedure volume within centers performing complex endovascular aortic repair. However, complication rates and endoleak may be associated with procedure volume. Long-term outcomes by annualized procedure volume, specifically graft durability and sac expansion, should be investigated.
引用
- Hawkins A, Jin R, Clouse WD, et al. Center-level outcomes following elective fenestrated endovascular aortic aneurysm repair in the Vascular Quality Initiative database. J Vasc Surg. 2024. PMID: 38604317. doi:10.1016/j.jvs.2024.03.453
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。